The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines
- 1 July 2015
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 84, 22-29
Abstract
No abstract availableKeywords
Funding Information
- Fondation Georges Lemaitre, Geneva, Switzerland
This publication has 65 references indexed in Scilit:
- Anaplastic large cell lymphoma, ALK-negativeCritical Reviews in Oncology/Hematology, 2013
- Sténoses carotidiennesArchives des Maladies du Coeur et des Vaisseaux - Pratique, 2012
- Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vesselsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Radical Decisions in Cancer: Redox Control of Cell Growth and DeathCancers, 2012
- Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung CancersScience Translational Medicine, 2012
- Cross talk between mitochondria and NADPH oxidasesFree Radical Biology and Medicine, 2011
- Molecular regulation of NADPH oxidase 5 via the MAPK pathwayAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology and Medicine, 2010
- Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-AblFree Radical Biology and Medicine, 2008
- Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyLeukemia, 2003